Skip to content
Latest briefingsTopicsCompaniesGlossaryAbout
Companies

Warp Sciences

U.S. preclinical contract research company co-founded by Kevin Weil that makes and tests drug-discovery molecules for pharma and biotech customers, using chemists, AI and lab robots.

1 articlesLast covered

warp.xyz ↗

Key developments

  1. FundingKevin Weil's Warp Sciences raises $215 million to build robotic chemistry labs in the US

Coverage

Funding & Companies

Kevin Weil's Warp Sciences raises $215 million to build robotic chemistry labs in the US

Former OpenAI product chief Kevin Weil launched Warp Sciences on Oct. 22 with a $215 million Series A led by Lightspeed Venture Partners; TechCrunch, citing Weil, said the round values Warp at $865 million. Warp will make and test molecules for drug developers in the United States, starting with human chemists and automating their work over time.

1 min readSources verified